Cyclin D1 and human neoplasia.

Neoplasia is characterised by abnormal regulation of the cell cycle. Cyclin D1 is a protein derived from the PRAD1, CCND1 or bcl-1 gene on chromosome 11q13, which is involved in both normal regulation of the cell cycle and neoplasia. In the G1 (resting) phase of the cell cycle, cyclin D1 together with its cyclin dependent kinase (cdk) partner, is responsible for transition to the S (DNA synthesis) phase by phosphorylating the product of the retinoblastoma gene (pRB), which then releases transcription factors important in the initiation of DNA replication. Amplification of the CCND1 gene or overexpression of the cyclin D1 protein releases a cell from its normal controls and causes transformation to a malignant phenotype. Analysis of these changes provides important diagnostic information in mantle cell (and related) lymphomas, and is of prognostic value in many cancers. Knowledge of cyclin D1's role in malignancy at the various sites, provides a basis on which future treatment directed against this molecule can proceed.

[1]  R. Chetty,et al.  Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma. , 1997, Molecular pathology : MP.

[2]  M. Vasef,et al.  Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  F. O'Malley,et al.  Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. , 1997, The American journal of pathology.

[4]  D. Hochhauser,et al.  Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. , 1997, British Journal of Cancer.

[5]  K. Maeda,et al.  Overexpression of cyclin D1 and p53 associated with disease recurrence in colorectal adenocarcinoma , 1997, International journal of cancer.

[6]  S. Gansauge,et al.  Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. , 1997, Cancer research.

[7]  A. Hart,et al.  Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. , 1997, Archives of otolaryngology--head & neck surgery.

[8]  M. Monden,et al.  Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer. , 1997, Journal of clinical pathology.

[9]  A. Marchetti,et al.  Cyclin‐d1‐gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression , 1997, International journal of cancer.

[10]  Y. Doki,et al.  Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. , 1997, Cancer research.

[11]  M. Seto,et al.  Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma. , 1997, Leukemia.

[12]  J. Downward,et al.  Cell cycle: Routine role for Ras , 1997, Current Biology.

[13]  C. Dees,et al.  Dietary estrogens stimulate human breast cells to enter the cell cycle. , 1997, Environmental health perspectives.

[14]  G. Pruneri,et al.  Molecular and immunohistochemical analysis of the bcl‐1/cyclin D1 gene in laryngeal squamous cell carcinomas , 1997, Cancer.

[15]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[16]  A. Rustgi,et al.  The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach , 1997, Oncogene.

[17]  P. Dirks,et al.  Cyclin and Cyclin‐Dependent Kinase Expression in Human Astrocytoma Cell Lines , 1997, Journal of neuropathology and experimental neurology.

[18]  G. Koh,et al.  Temporal expressions of cyclins and cyclin dependent kinases during renal development and compensatory growth. , 1997, Kidney international.

[19]  D. Barnes.  Cyclin D1 in mammary carcinoma , 1997, The Journal of pathology.

[20]  R. Morris,et al.  Increased expression of G1 cyclins and cyclin‐dependent kinases during tumor progression of chemically induced mouse skin neoplasms , 1997, Molecular carcinogenesis.

[21]  S. Fukushima,et al.  Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features , 1997, Cancer.

[22]  H. Müller-Hermelink,et al.  Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. , 1997, Blood.

[23]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[24]  B. Ponder,et al.  Overexpression of cyclin D1 in epithelial ovarian cancers. , 1997, Gynecologic oncology.

[25]  P. V. van Diest,et al.  Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. , 1997, The American journal of pathology.

[26]  G. Landberg,et al.  Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein , 1997, Oncogene.

[27]  F. Mertens,et al.  Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.

[28]  W. Farrell,et al.  Tumour suppressor genes in the pathogenesis of human pituitary tumours. , 1997, Hormone research.

[29]  R. DuBois,et al.  Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. , 1997, Cancer research.

[30]  P. Hasleton,et al.  Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. , 1997, British Journal of Cancer.

[31]  G. Kong,et al.  Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. , 1997, British Journal of Cancer.

[32]  N. Ragni,et al.  Expression of cyclin D1 correlates with malignancy in human ovarian tumours. , 1997, British Journal of Cancer.

[33]  W. Hung,et al.  Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors. , 1996, Human Pathology.

[34]  A. Ariza,et al.  CYCLIN D1 OVEREXPRESSION IN NON‐SMALL CELL LUNG CARCINOMA: CORRELATION WITH Ki67 LABELLING INDEX AND POOR CYTOPLASMIC DIFFERENTIATION , 1996, The Journal of pathology.

[35]  T. Nikaido,et al.  Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas , 1996, Cancer.

[36]  P Boracchi,et al.  Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  R. Zeillinger,et al.  Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors , 1996, International journal of cancer.

[38]  M. Masuda,et al.  Cyclin D1 overexpression in primary hypopharyngeal carcinomas , 1996, Cancer.

[39]  J. Bartek,et al.  Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. , 1996, Oncogene.

[40]  H. Frierson,et al.  Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[41]  M. Kitajima,et al.  Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  E. Jaffe,et al.  bcl-1 Rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis , 1996 .

[43]  W. Mooi,et al.  The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. , 1996, Lung cancer.

[44]  A. Arnold,et al.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. , 1996, The Journal of clinical endocrinology and metabolism.

[45]  G. Peters,et al.  Cyclin D1 and prognosis in human breast cancer , 1996, International journal of cancer.

[46]  M. Gaffey,et al.  Cyclin D1 gene expression in human cervical neoplasia. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[47]  D. Shin,et al.  Cyclin D1 protein expression in lung cancer. , 1996, Yonsei medical journal.

[48]  H. Hibshoosh,et al.  Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. , 1996, Gastroenterology.

[49]  D. Betticher.  Cyclin D1, another molecule of the year? , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  J. Peterse,et al.  A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. , 1996, British Journal of Cancer.

[51]  W. Ryder,et al.  Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. , 1996, British Journal of Cancer.

[52]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[53]  S. Inohara,et al.  Expression of cyclin D1 and p53 protein in various malignant skin tumors. , 1996, Dermatology.

[54]  I. Weinstein.  Relevance of cyclin D1 and other molecular markers to cancer chemoprevention , 1996, Journal of cellular biochemistry. Supplement.

[55]  M. Merino,et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[56]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[57]  E. Schuuring,et al.  Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. , 1995, Blood.

[58]  B. Angus,et al.  Determination of the prognostic value of cyclin D1 overexpression in breast cancer. , 1995, Oncogene.

[59]  N. Harris,et al.  Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. , 1995, Human pathology.

[60]  M. Seto,et al.  The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma , 1995, Japanese journal of cancer research : Gann.

[61]  C. Cordon-Cardo.  Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. , 1995, The American journal of pathology.

[62]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[63]  I. Schieren,et al.  Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. , 1995, Oncogene.

[64]  H. Koeffler,et al.  Role of the cyclin-dependent kinase inhibitors in the development of cancer. , 1995, Blood.

[65]  E. Hovig,et al.  Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1. , 1995, British Journal of Cancer.

[66]  E. Schuuring.  The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review. , 1995, Gene.

[67]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[68]  M. J. Silverstein,et al.  Prognostic classification of breast ductal carcinoma-in-situ , 1995, The Lancet.

[69]  E. Schuuring,et al.  Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. , 1995, Oncogene.

[70]  T. Hattori,et al.  Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. , 1995, The American journal of pathology.

[71]  A. Hart,et al.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.

[72]  J. Bartek,et al.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. , 1995, Oncogene.

[73]  M. Strauss,et al.  Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. , 1995, Cancer research.

[74]  R. Kurzrock,et al.  Abnormalities in the PRAD1 (CYCLIN D1 / BCL‐1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines , 1995, Cancer.

[75]  内藤 弘之.  Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer , 1995 .

[76]  M. Seto,et al.  Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma , 1994, Japanese journal of cancer research : Gann.

[77]  O. Cussenot,et al.  Oncogene amplifications in early‐stage human prostate carcinomas , 1994, International journal of cancer.

[78]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[79]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[80]  Jun-yan Hong,et al.  Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric‐cardia carcinogenesis , 1994, International journal of cancer.

[81]  C. James,et al.  CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. , 1994, Cancer research.

[82]  A. Klein-Szanto,et al.  Immunohistochemistry of cyclin D1 in human breast cancer. , 1994, American journal of clinical pathology.

[83]  A. López-Guillermo,et al.  PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .

[84]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[85]  M. Seto,et al.  Monoclonal Antibody against PRADl/Cyclin Dl Stains Nuclei of Tumor Cells with Translocation or Amplification at BCL‐1 Locus , 1994, Japanese journal of cancer research : Gann.

[86]  M. Pagano,et al.  Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. , 1994, Oncogene.

[87]  F. Bosch,et al.  PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.

[88]  K. Kok,et al.  A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. , 1994, Cancer research.

[89]  A. El‐Naggar,et al.  PRAD‐1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma , 1994, Cancer.

[90]  B. Klein,et al.  Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. , 1994, Blood.

[91]  N. Nishida,et al.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.

[92]  L. Bonetta,et al.  Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. , 1994, Oncogene.

[93]  H. Ohno,et al.  Clinical aspects of B-cell malignancy involving the BCL1/PRAD1 locus. , 1994, International journal of hematology.

[94]  Jiri Bartek,et al.  Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.

[95]  J. Bartek,et al.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.

[96]  J. Bartek,et al.  Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[97]  N. Takakura,et al.  PRAD1 gene over‐expression in mantle‐cell lymphoma but not in other low‐grade B‐cell lymphomas, including extranodal lymphoma , 1994, British journal of haematology.

[98]  J. Bartek,et al.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.

[99]  M. Gossen,et al.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[100]  R. Weinberg,et al.  Tumor suppressor genes. , 1994, Current opinion in genetics & development.

[101]  R. Thakker,et al.  Molecular genetic studies of sporadic pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[102]  G. Peters.  The D-type cyclins and their role in tumorigenesis , 1994, Journal of Cell Science.

[103]  A. López-Guillermo,et al.  PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. , 1994, Blood.

[104]  Pengcheng Zhou,et al.  Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. , 1993, Oncogene.

[105]  C. J. Chen,et al.  Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. , 1993, Biochemical and biophysical research communications.

[106]  C. Harris,et al.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[107]  J. A. Hamilton,et al.  Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.

[108]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[109]  F. Berger,et al.  Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. , 1993, Blood.

[110]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[111]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[112]  S. Elledge,et al.  Amplification of cyclin genes in colorectal carcinomas. , 1993, Cancer research.

[113]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[114]  M. Ewen,et al.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.

[115]  A. Arnold,et al.  Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. , 1993, Oncogene.

[116]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[117]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[118]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[119]  S. Pileri,et al.  Mantle Cell Lymphoma , 2022, The EBMT/EHA CAR-T Cell Handbook.

[120]  I. Weinstein,et al.  Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.

[121]  J. Foekens,et al.  Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.

[122]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[123]  N. Harris,et al.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[124]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[125]  Pearl S Huang,et al.  Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product , 1991, Nature.

[126]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[127]  J. Cairns,et al.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.

[128]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[129]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[130]  Y. Kitagawa,et al.  Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. , 1991, Cancer research.

[131]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[132]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[133]  M. Fernö,et al.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.

[134]  Rogler Ce.  Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. , 1991 .

[135]  C. Rogler,et al.  Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. , 1991, Current topics in microbiology and immunology.

[136]  F. Beuvon,et al.  Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells? , 1990, Journal of cellular biochemistry.

[137]  R. Figlin,et al.  Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. , 1990, Oncogene.

[138]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[139]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[140]  T. Sugimura,et al.  High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. , 1989, Cancer research.

[141]  G. Juliusson,et al.  An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy. , 1989, Blood.

[142]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[143]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[144]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[145]  D. Birnbaum,et al.  Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. , 1989, Oncogene.

[146]  T. Sugimura,et al.  HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder. , 1989, Japanese journal of clinical oncology.

[147]  T. Ochiya,et al.  Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. , 1988, Oncogene.

[148]  T. Tokino,et al.  Microdeletion associated with the integration process of hepatitis B virus DNA. , 1988, Nucleic acids research.

[149]  Teruhiko Yoshida,et al.  COAMPLIFICATION OF THE hst‐1 AND int‐2 GENES IN HUMAM CANCERS , 1988, Japanese journal of cancer research : Gann.

[150]  R. Weinberg,et al.  Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[151]  Wen-Hwa Lee,et al.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.

[152]  S. Hinrichs,et al.  Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.

[153]  R. Chetty,et al.  Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma. , 1997, Molecular pathology : MP.